@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_head { this: np:hasAssertion dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_assertion; np:hasProvenance dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_provenance; np:hasPublicationInfo dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_publicationInfo; a np:Nanopublication . dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_assertion a np:Assertion . dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_provenance a np:Provenance . dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_publicationInfo a np:PublicationInfo . } dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_assertion { miriam-gene:5291 a ncit:C16612 . lld:C0025202 a ncit:C7057 . dgn-gda:DGN8fc7c4d45eae598a039c0b3108f382b2 sio:SIO_000628 miriam-gene:5291, lld:C0025202; a sio:SIO_001121 . } dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_provenance { dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_assertion dcterms:description "[The most promising include: i) vertical targeting of either MEK or phosphoinositide-3 kinase (PI3K)/mammalian target of rapamycin (mTOR) pathways, or their combined blockade; ii) association of receptor tyrosine kinases (RTKs) inhibitors with other pro-apoptotic strategies; iii) engagement of death receptors in combination with MEK-, mTOR/PI3K-, histone deacetylase (HDAC)-inhibitors, or with anti-apoptotic molecules modulators; iv) strategies aimed at blocking anti-apoptotic proteins belonging to B-cell lymphoma (Bcl-2) or inhibitors of apoptosis (IAP) families associated with MEK/BRAF/p38 inhibition; v) co-inhibition of other molecules important for survival [proteasome, HDAC and Signal transducers and activators of transcription (Stat)3] and the major pathways activated in melanoma; vi) simultaneous targeting of multiple anti-apoptotic molecules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:24920406; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP622545.RAiz9ozscM8wI7YD-8C9ln-7irRg0kcSJM43v1y7WY3uQ130_publicationInfo { this: dcterms:created "2015-08-25T14:43:52+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }